Scientific Presentations and Peer-Reviewed Publications

Prolific Producers of Scientific Content

Our researchers have published 2,400+ peer-reviewed articles dating back to 1974. We publish 130+ peer-reviewed articles and 220+ research posters and presentations per year, along with numerous white papers and webinars. We’ve published across a variety of noteworthy journals with high impact factors, including: Journal of the American Medical Association (JAMA), European Journal of Health Economics, British Journal of Cancer, Journal of Clinical Oncology, Value in Health, PharmacoEconomics, Health Affairs, Medical Decision Making, among others.

Published Across All Major Therapeutic Areas and Study Types

Evidera Presentations Peer-Reviewed Publications

Latest Publications

Cardiovascular

Net Clinical Benefit of Antiplatelet Therapy was Affected by Patient Preferences: A Personalized Benefit-Risk Assessment

February 2022

Endocrinology

Cost-Effectiveness of Second-Line Empagliflozin versus Liraglutide for Type 2 Diabetes in the United States

Diabetes Obesity & Metabolism
February 2022

Nephrology

Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG Outcome Trial

American Journal of Kidney Diseases
February 2022

Thought Leadership

Resource Center